ABL Bio Inc

298380

Company Profile

  • Business description

    ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

  • Contact

    2nd Floor, 16 Daewangpangyo-Ro 712
    Beon-Gil, Bundang-Gu
    Gyeonggi-do
    Seongnam-si13488
    KOR

    T: +82 3180189800

    https://www.ablbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    102

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,374.0082.20-0.97%
CAC 407,727.9342.55-0.55%
DAX 4023,344.54257.891.12%
Dow JONES (US)41,389.6872.250.17%
FTSE 1008,596.3599.551.17%
HKSE22,504.68385.271.74%
NASDAQ17,928.8448.89-0.27%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,421.2593.360.76%
S&P 5005,674.8311.84-0.21%
S&P/ASX 2008,157.8080.20-0.97%
SSE Composite Index3,279.037.62-0.23%

Market Movers